Petrolimex Hanoi Transportation and Trading JSC (HNX:PJC)
Vietnam · Delayed Price · Currency is VND 28,000
0.00 (0.00%)
At close: Aug 4, 2025
Sage Therapeutics Income Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2019 | FY 2018 | 2019 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2019 - 2020 |
| 1,186,671 | 1,188,945 | 1,201,256 | 1,197,198 | 1,122,765 | 1,169,534 | Upgrade | |
Revenue Growth (YoY) | -1.49% | -1.03% | 0.34% | 6.63% | -4.00% | -2.81% | Upgrade |
Cost of Revenue | 1,049,766 | 1,068,264 | 1,089,166 | 1,113,133 | 1,050,086 | 1,101,372 | Upgrade |
Gross Profit | 136,905 | 120,681 | 112,090 | 84,065 | 72,678 | 68,162 | Upgrade |
Selling, General & Admin | 101,157 | 89,774 | 82,695 | 52,198 | 40,580 | 36,846 | Upgrade |
Operating Expenses | 101,157 | 89,774 | 82,695 | 52,198 | 40,580 | 36,846 | Upgrade |
Operating Income | 35,748 | 30,907 | 29,395 | 31,867 | 32,099 | 31,316 | Upgrade |
Interest Expense | -152.85 | -4.62 | -15.25 | - | -4,552 | -958.31 | Upgrade |
Interest & Investment Income | 320.79 | 653.71 | 2,199 | 794.74 | 20.82 | 217.44 | Upgrade |
Other Non Operating Income (Expenses) | 1,710 | 1,796 | 7,857 | -1,384 | 1,414 | 1,175 | Upgrade |
EBT Excluding Unusual Items | 37,626 | 33,352 | 39,435 | 31,277 | 28,982 | 31,750 | Upgrade |
Gain (Loss) on Sale of Investments | -112.27 | -112.27 | 191.7 | - | - | - | Upgrade |
Gain (Loss) on Sale of Assets | 394.44 | 394.44 | 186.36 | - | - | - | Upgrade |
Pretax Income | 37,908 | 33,634 | 39,813 | 31,277 | 28,982 | 31,750 | Upgrade |
Income Tax Expense | 8,110 | 7,173 | 8,083 | 6,482 | 5,891 | 6,451 | Upgrade |
Net Income | 29,798 | 26,461 | 31,730 | 24,795 | 23,091 | 25,299 | Upgrade |
Preferred Dividends & Other Adjustments | - | - | 2,938 | - | - | - | Upgrade |
Net Income to Common | 29,798 | 26,461 | 28,792 | 24,795 | 23,091 | 25,299 | Upgrade |
Net Income Growth | -12.69% | -16.61% | 27.97% | 7.38% | -8.73% | 131.08% | Upgrade |
Shares Outstanding (Basic) | 7 | 7 | 7 | 7 | 6 | 6 | Upgrade |
Shares Outstanding (Diluted) | 7 | 7 | 7 | 7 | 6 | 6 | Upgrade |
Shares Change (YoY) | 1.29% | - | -0.12% | 25.14% | 0.01% | -0.00% | Upgrade |
EPS (Basic) | 4014.72 | 3611.57 | 3929.66 | 3380.00 | 3939.00 | 4316.00 | Upgrade |
EPS (Diluted) | 4014.72 | 3611.57 | 3929.66 | 3380.00 | 3939.00 | 4316.00 | Upgrade |
EPS Growth | -5.68% | -8.09% | 16.26% | -14.19% | -8.73% | 131.08% | Upgrade |
Free Cash Flow | 22,312 | -24,315 | 12,664 | 67,241 | -43,675 | -33,451 | Upgrade |
Free Cash Flow Per Share | 3006.05 | -3318.67 | 1728.47 | 9166.08 | -7450.50 | -5706.83 | Upgrade |
Dividend Per Share | 1500.000 | 1500.000 | - | - | - | - | Upgrade |
Gross Margin | 11.54% | 10.15% | 9.33% | 7.02% | 6.47% | 5.83% | Upgrade |
Operating Margin | 3.01% | 2.60% | 2.45% | 2.66% | 2.86% | 2.68% | Upgrade |
Profit Margin | 2.51% | 2.23% | 2.40% | 2.07% | 2.06% | 2.16% | Upgrade |
Free Cash Flow Margin | 1.88% | -2.04% | 1.05% | 5.62% | -3.89% | -2.86% | Upgrade |
EBITDA | 64,133 | 60,442 | 62,583 | 70,368 | 76,759 | 62,538 | Upgrade |
EBITDA Margin | 5.40% | 5.08% | 5.21% | 5.88% | 6.84% | 5.35% | Upgrade |
D&A For EBITDA | 28,385 | 29,535 | 33,188 | 38,501 | 44,661 | 31,223 | Upgrade |
EBIT | 35,748 | 30,907 | 29,395 | 31,867 | 32,099 | 31,316 | Upgrade |
EBIT Margin | 3.01% | 2.60% | 2.45% | 2.66% | 2.86% | 2.68% | Upgrade |
Effective Tax Rate | 21.39% | 21.32% | 20.30% | 20.72% | 20.33% | 20.32% | Upgrade |
Revenue as Reported | 1,186,671 | 1,188,945 | 1,201,256 | 1,197,198 | 1,122,765 | 1,169,534 | Upgrade |
Updated Mar 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.